Common TitleMAGELLAN-1 (Part 2)
Official Title Glecaprevir/Pibrentasvir in Patients with HCV Genotype 1 or 4 and Prior Direct-acting Antiviral Treatment Failure.
Phase Phase III
ClinicalTrials.gov NCT02446717
Treatments
Glecaprevir-Pibrentasvir

Glecaprevir-Pibrentasvir
Tradename:MavyretOther Names:GLE-PIBClass:FDA-ApprovedFunding
IndustryAbbVie